Fifth Third Bancorp
BBNX

Fifth Third Bancorp’s Beta Bionics BBNX Stock Holding History

Fifth Third Bancorp’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447 Sell
29
-90
-76% -$1.07K ﹤0.01% 4240
2026
Q1 		$1.19K Buy
+119
New +$1.76K ﹤0.01% 4113

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fifth Third Bancorp's BBNX Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Beta Bionics (BBNX) stake by 76% in Q2 2026, selling an estimated $1.07K and leaving 29 shares worth $447. The position accounts for ﹤0.01% of the portfolio, ranked #4240.

Fifth Third Bancorp first reported a position in BBNX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.19K in Q1 2026. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Fifth Third Bancorp held 29 shares of Beta Bionics worth $447 as of Q2 2026.
  • Fifth Third Bancorp sold 90 Beta Bionics shares in Q2 2026, an estimated $1.07K.
  • Beta Bionics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4240 holding.
  • Fifth Third Bancorp first reported a position in Beta Bionics in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Beta Bionics position peaked at $1.19K in Q1 2026.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.